https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Cancer Invest. 2001;19(8):791-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Cancer Invest. 2001;19(8):791-82001-01-01 00:00:002001-01-01 00:00:00Effect of hyperthermia on AKR lymphoma variants differing in degree of malignancy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-312001-01-01 00:00:002019-02-15 08:53:40Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-62001-01-01 00:00:002019-02-15 08:53:39In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-922001-01-01 00:00:002019-02-15 08:51:14Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Intervirology 2001;44(4):199-208
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Intervirology 2001;44(4):199-2082001-01-01 00:00:002019-02-15 08:37:58Dendritic cells and chronic hepatitis virus carriers
